SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form N-CSR - Certified Shareholder Report:
SEC Accession No. 0001193125-24-037128
Filing Date
2024-02-15
Accepted
2024-02-15 08:52:30
Documents
4
Period of Report
2023-12-31
Effectiveness Date
2024-02-15

Document Format Files

Seq Description Document Type Size
1 HEALTH SCIENCES PORTFOLIO_HSP_E309-050 d696506dncsr.htm N-CSR 3422551
2 302 CERTIFICATIONS d696506dex99cert.htm EX-99.CERT 20677
3 906 CERTIFICATIONS d696506dex99906ce.htm EX-99.906CE 4656
4 CODE OF ETHICS d696506dex99codeeth.htm EX-99.CODE ETH 26789
  Complete submission text file 0001193125-24-037128.txt   3476359

Series and Classes/Contracts Information:

Existing
  Status Name Ticker Symbol
CIK 0000918294      
Series S000002083   T. Rowe Price Health Sciences Portfolio
Class/Contract C000005448   T. Rowe Price Health Sciences Portfolio QAAGZX
Class/Contract C000005449   T. Rowe Price Health Sciences Portfolio-II QAAHBX
Mailing Address 100 EAST PRATT STREET BALTIMORE MD 21202
Business Address 100 EAST PRATT STREET BALTIMORE MD 21202 410-345-2000
T. Rowe Price Equity Series, Inc. (Filer) CIK: 0000918294 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231
Type: N-CSR | Act: 40 | File No.: 811-07143 | Film No.: 24642315